Literature DB >> 29684707

Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis.

Ratna Kancana Wolfram1, Lucie Heller1, René Csuk2.   

Abstract

Triterpenoic acids, ursolic acid (1), oleanolic acid (2), glycyrrhetinic acid (3) and betulinic acid (4) were converted into their corresponding methyl 5-8 and benzyl esters 9-12 or benzyl amides 21-24. These derivatives served as starting materials for the synthesis of pink colored rhodamine B derivatives 25-36 which were screened for cytotoxicity in colorimetric SRB assays. All of the compounds were cytotoxic for a variety of human tumor cell lines. The activity of the benzyl ester derivatives 29-32 was lower than the cytotoxicity of the methyl esters 25-28. The benzyl amides 33-36 were the most cytotoxic compounds of this series. The most potential compound was a glycyrrhetinic acid rhodamine B benzyl amide 35. This compound showed activity against the different cancer cell lines in a two-digit to low three-digit nano-molar range. Staining experiments combined with fluorescence microscopy showed that this compound triggered apoptosis in A2780 ovarian carcinoma cells and acted as a mitocan.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Triterpenes; apoptosis; glycyrrhetinic acid; mitocan

Mesh:

Substances:

Year:  2018        PMID: 29684707     DOI: 10.1016/j.ejmech.2018.04.031

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions.

Authors:  Haider N Sultani; Ibrahim Morgan; Hidayat Hussain; Andreas H Roos; Haleh H Haeri; Goran N Kaluđerović; Dariush Hinderberger; Bernhard Westermann
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

2.  Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate.

Authors:  Ioana Macașoi; Ioana Zinuca Pavel; Alina Elena Moacă; Ștefana Avram; Vlad Laurențiu David; Dorina Coricovac; Alexandra Mioc; Demetrios A Spandidos; Aristidis Tsatsakis; Codruța Șoica; Victor Dumitrașcu; Cristina Dehelean
Journal:  Oncol Rep       Date:  2020-06-26       Impact factor: 3.906

Review 3.  DNA Vaccines-How Far From Clinical Use?

Authors:  Dominika Hobernik; Matthias Bros
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

4.  Betulinic Acid Suppresses Ovarian Cancer Cell Proliferation through Induction of Apoptosis.

Authors:  Dahae Lee; Seoung Rak Lee; Ki Sung Kang; Yuri Ko; Changhyun Pang; Noriko Yamabe; Ki Hyun Kim
Journal:  Biomolecules       Date:  2019-07-03

5.  Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity.

Authors:  Halil I Ciftci; Mohamed O Radwan; Safiye E Ozturk; N Gokce Ulusoy; Ece Sozer; Doha E Ellakwa; Zeynep Ocak; Mustafa Can; Taha F S Ali; Howaida I Abd-Alla; Nurettin Yayli; Hiroshi Tateishi; Masami Otsuka; Mikako Fujita
Journal:  Molecules       Date:  2019-09-30       Impact factor: 4.411

Review 6.  Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.

Authors:  Sophie Hoenke; Immo Serbian; Hans-Peter Deigner; René Csuk
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

Review 7.  Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer.

Authors:  Liang Shen; Xianquan Zhan
Journal:  Oxid Med Cell Longev       Date:  2022-04-20       Impact factor: 7.310

8.  Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs.

Authors:  Niels V Heise; Daniel Major; Sophie Hoenke; Marie Kozubek; Immo Serbian; René Csuk
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

Review 9.  Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria.

Authors:  Anna Yu Spivak; Darya A Nedopekina; Rinat R Gubaidullin; Mikhail V Dubinin; Konstantin N Belosludtsev
Journal:  J Pers Med       Date:  2021-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.